InterventionsHuman trial
RNA INTERFERENCE OF ANGPTL3 VIA ZODASIRAN: A NEXT-GENERATION APPROACH FOR TREATING ATHEROGENIC DYSLIPIDEMIA
AHA Scientific Sessions 2025 Abstract
The paper
Hadrian Tran, Audrey Thu, Anu Radha Twayana, Wilbert S. Aronow
Show 8 more authors
Axel Fuertes, Marco Gonzalez, Marina Basta, Maggie James, Ashwini Mahadevaiah, Krutagni Adwait Mehta, Damien Islek, William H. Frishman,HMH - Palisades Medical Center · New York Medical College
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4358409